The CREATES Act – Stepping Closer to Drug Pricing Justice?

A blank doctor's prescription from a pharmacy is placed on American flag.

I don’t know about you, but the headlines on pharmaceutical companies substantially raising prices over a short period of time (without good reason) appear far too often for my taste – and we write about drug pricing issues frequently on this blog. But a quieter game of drug company manipulation has been taking place at… [Read More]

Generics: The Rx for Rising Pharmacy Costs

logo-sq-no-border

There are very few medical plan management decisions where there isn’t a cost associated with the financial benefit. If an employer increases its employees’ health plan contributions or restricts access to certain expensive health services, the cost of discouraging enrollment or limiting access is weighed against the benefit of continuing to offer a financially viable… [Read More]

Employers Find Solutions to Rx Gamesmanship That Increases Their Costs

Facing the erosion of profits due to high-cost brand name drugs coming off patent, the pharmaceutical industry has found a way to keep the profits rolling in. Pharma would like members who face higher copays and costs for name-brand medications with generic alternatives to stay on the branded drugs. To do so, they spend $3-$6… [Read More]